OHSU’s Vollum Institute is a scientific powerhouse, home to some of the world’s top minds dedicated to basic neuroscience research – that critical first step in developing new treatments for neurological and psychiatric disorders. Thanks in part to significant philanthropy, one lab at the Vollum has been unusually prolific, and it’s paying off. Eric Gouaux, […]
“Our covenant with patients is to use philanthropic funds carefully, to make sure they are directed to making a difference.” Gordon Mills, M.D., Ph,D., director of precision oncology at the OHSU Knight Cancer Institutes, describes the impact that philanthropy has on cancer science.
OHSU announced that internationally renowned scientist Gordon B. Mills, MD, PhD, has been recruited to lead precision oncology for the Knight Cancer Institute. Here are a few interesting facts about him.
Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks […]
Treatments for childhood cancers are harsh on kids’ bodies. While survival rates have improved dramatically over the last few decades, quality of life has not. Therapies such as chemotherapy and radiation can lead to learning disabilities, nerve damage, fertility issues and other health problems. OHSU cancer researchers are working to change that. Monika Davare, PhD, […]
The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]
OHSU Doernbecher Children’s Hospital has recruited Yoon-Jae Cho, M.D., thanks to a new endowed professorship from Wayne and Sandy Ericksen. Dr. Cho is the chief of the Division of Pediatric Neurology, Ericksen Family Endowed Professor for Research, and scientific director of the Pediatric Brain Tumor Program. He is also a graduate of OHSU School of […]
OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]
Fifteen years ago, an astounding breakthrough changed the way the world treats cancer. The discovery by Brian Druker, M.D., now director of the OHSU Knight Cancer Institute, turned chronic myeloid leukemia (CML) from a deadly disease with a very short life expectancy into a treatable condition managed by a daily pill, called Gleevec. It was […]
Missions to deep space involve risk. The National Space Biomedical Research Institute (NSBRI) — which works with NASA — has tapped OHSU’s Jonathan Lindner, MD to find better ways to screen astronaut candidates for cardiovascular damage before they reach deep space.
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
